Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.

Latest Resources

• 74% Of U.S. Adults Believe Chronic Disease Is Preventable, But Only 25% Feel Confident In Avoiding It
• Regen Therapy Partners With Stealth Health To Bring Specialized Telemedicine Services & Longevity Programs To 3,000 Clinics
• Breakthrough T1D Awards $1.5 Million Grant To Blue Circle Health To Expand Access To Care For Underserved Adults With Type 1 Diabetes
• Multiple Sclerosis Prevalence Doubled In Two Decades In England
• Prior Authorization Linked To Delays & Higher Non-Fill Rates For Heart Failure Medications
• CVS Health Foundation Awards $2.6 Million To Expand Maternal Diabetes Program In New York City
• Nimbus Healthcare & Snap Kitchen Launch Program Combining GLP-1 Therapy With Medically Tailored Meals
• Socioeconomically Disadvantaged Communities Have Significantly Less Access To Dialysis Care
• Chronilogix Announces Safety-Focused AI Platform For Mental Health & Chronic Care Coaching
• EmpiRx Health Launches Medication Optimization Operating Model
• GLP-1 Medications Linked To 15%–20% Lower Risk Of Substance Use Disorders In Veterans With Type 2 Diabetes
• Bariatric Surgery Volumes Declined 46% Over Three Years While GLP-1 Prescription Rates Increased
• Patient Care America Launches KidneyLyfe, A Digital Community For People Living With Kidney Disease
• Prescryptive & Ilant Health Expand Employer Access To Obesity Care & GLP-1 Therapies
• HealthDyne Supports Employer Carve-Out Options For Obesity Treatment Access

See All

13.6 Million People Were Dual Eligibles For At Least One Month In 2022

There were 13.6 million people who were fully or partially dually eligible for Medicare and Medicaid for at least one month in 2022, according to a recent report conducted by two independent congressional agencies, the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission. Combined state and federal spending for dual eligibles totaled $548.8 billion in calendar year 2022. Medicare accounted for $351.4 billion (64%). About 38% of dual eligibles were… Read

• The Obesity Association Publishes New Standards Of Care Section On Obesity Medications
• 19.8% Of U.S. Youth Ages 2 To 19 Had Obesity In 2024
• Primary Care Use Linked To Lower Mortality Among People Receiving Dialysis
• Obesity Rates Doubled Among Adults & Children In The United States Between 1988 & 2023
• Cardiovascular Risk Factors Projected To Rise Among U.S. Women & Girls

To sign-up for monthly Chronic Disease Management alerts, you must be signed in to your account.